The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded an Indefinite Delivery Contract (IDC) to Naveris Inc., a for-profit organization, for NAVDX blood testing services. The single-award contract, which does not have a set-aside designation, has a potential value of $968,000.00 and a completion date of April 30, 2025.
Under this IDC, the VA issued a firm fixed-price delivery order with a ceiling value of $176,000.00 for NAVDX blood testing services to be performed in Bronx, New York. The NAVDX test detects a DNA biomarker unique to HPV positive cancers and is used to identify such cancers, track treatment progress, provide cancer-free status, and detect early signs of recurrence. The VA cited the authority of 41 U.S.C. 3304(a)(1) and FAR 13.106-1(b) in its intent to award this sole source contract to Naveris Inc., as the agency determined it was the only responsible source that could fully meet the requirement.
Generated 8/8/24, 9:04 AM